Abiopharma

News list

Director Habiger David C 🟢 acquired 29.3K shares of Xperi Inc. (XPER) Transaction Date: Apr 17, 2026 | Filing ID: 046048

Full text

News bot April 21, 2026, 8:31 p.m.
🔍 Habiger David C (Director)

Company: Xperi Inc. (XPER)

Report Date: 2026-04-17
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 29,320
- Total shares held: 6,900
Detailed Transactions and Holdings:
- Acquired 29,320 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 129,115.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: H | nature_of_ownership: By David C. Habiger Family Trust | shares_owned_after: 6,900.00
Footnotes:
- F1: On April 17, 2026, the Reporting Person was granted 29,320 restricted stock units vesting in full on the earlier of (a) April 17, 2027, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant. Each restricted stock unit represents a contingent right to receive one share of Xperi Inc. common stock.